TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EBS

Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EBS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.45 0.94 1.08 4.14 0.81 3.59 9.98 5.94 -0.68 -4.03 1.11 3.01
0.71 0.75 0.77 0.85 1.21 2.11 2.13 2.29 2.86 2.44 2.05 1.69
0.28 0.34 0.37 0.30 0.45 0.51 0.96 0.78 0.90 0.45 0.34 0.29
0.61 0.48 0.18 0.58 0.70 1.19 1.93 2.19 0.83
0.30 -1.39 -0.92 1.07 -2.32 -0.81 0.18 -2.89 -0.04 -1.37 1.67 -0.40
0.67 0.95 1.55 1.09 1.40 1.66 2.64 4.16 2.31 1.01 0.43 0.24
-4.59 -0.96 -1.55 -4.97 -17.46 -1.85 -2.82 -4.16 -7.61 4.15 2.36 1.22
0.98 0.00 0.00 0.00 0.02 0.33 0.29 0.10
0.00 0.00 -0.02 -0.66 0.00 -0.14 -0.26 -1.96 -1.64 -1.60 0.46 -0.44
3.94 0.04 -0.41 -0.45 15.23 0.26 1.01 -0.66 11.26 -10.61 -3.74 -1.92
4.34 0.71 -0.38 -1.02 15.34 -0.69 1.29 -2.61 9.60 -10.46 -3.58 -2.41
2.21 0.68 -0.84 -1.85 -1.30 1.06 8.43 -0.84 1.32 -10.37 -0.12 1.83
1.78 -0.01 -0.46 3.05 -0.59 1.93 7.34 1.78 -2.99 -5.04 0.68 2.77

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?